D-0718-2022 Class II Terminated

Recalled by Olympia Compounding Pharmacy Dba Olympia Pharmacy — Orlando, FL

FDA drug recall D-0718-2022 was initiated by Olympia Compounding Pharmacy Dba Olympia Pharmacy on Mar 8, 2022 and is designated Class II. Reason for recall: Sub Potent The recall status is terminated (terminated Oct 4, 2023). Affected quantity: 2283 vials.

Recall Details

Product Type
Drugs
Report Date
Mar 30, 2022
Initiation Date
Mar 8, 2022
Termination Date
Oct 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2283 vials

Product Description

Sermorelin Acetate Lyophilized powder for reconstitution, Multi-Dose 9 mg per vial, Each ML contains: 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0059-00

Reason for Recall

Sub Potent

Distribution Pattern

Nationwide in the USA including Puerto Rico.

Code Information

Lots: D44026 Exp. 4/26/22; F42104 Exp. 6/4/22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0718-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.